Trending Now
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA | Ophthalmology Times
Q&A: The ARCHER trial and the importance of continued GA research | Ophthalmology Times
Q&A: Frank Holz shares how innovation showcased at EURETINA brings hope for patients with GA | Ophthalmology Times
Breaking News
Surgical innovation in dry eye disease: Salivary gland transplant
Ağustos 27, 2025
Next-generation IOLs advance complex cataract care
Ağustos 26, 2025
OCT changes with low-level red light therapy for myopia in children
Ağustos 26, 2025
Alcon presenting at APACRS 2025
Ağustos 21, 2025
Breaking News
Popular Now
FDA grants breakthrough therapy designation to Nacuity’s NPI-001 for retinitis pigmentosa | Ophthalmology Times
(Image Credit: AdobeStock) The US Food and Drug Administration (FDA) has granted…
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA | Ophthalmology Times
(Image Credit: AdobeStock/artacet) The US Food and Drug Administration (FDA) has granted…
Q&A: The ARCHER trial and the importance of continued GA research | Ophthalmology Times
(Image credit: AdobeStock/J Bettencourt) In conversation with Sydney M. Crago, Managing Editor…
Charles Miller, MD, PhD, on DME research and the initiation of the phase 2b/3 BRUNELLO trial | Ophthalmology Times
Image credit: AdobeStock/MrAshi On September 4, 2025, Merck and EyeBio announced that…
Collaborate With Us
Join forces with Ophthalmology News to reach a global community of eye care professionals. Whether you want to contribute an article, share research, or explore partnership opportunities, we’d love to hear from you.
Editor Choice
Oculis and the Emerging Paradigm Shift in Ophthalmic Therapeutics: A Case for Strategic Investment – AInvest
Oculis and the Emerging Paradigm Shift in Ophthalmic Therapeutics: A Case for…
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences – The Manila Times
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute…
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences – Yahoo Finance
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute…
Don’t watch TV, laptop and phones screens in darkness – Ophthalmic nurse cautions public – Modern Ghana
Don’t watch TV, laptop and phones screens in darkness – Ophthalmic nurse…
Eyesore: GMCH’s eye dept in poor condition – The Times of India
Eyesore: GMCH’s eye dept in poor condition The Times of India Source: Author:…
At the root of ophthalmology’s issues – insightnews.com.au
At the root of ophthalmology’s issues insightnews.com.au Source: Author: | Date: 2025-08-31 22:58:00…
Barti Software raises $12M Series A for AI-powered electronic health records for eye care – Ophthalmology Times
Barti Software raises $12M Series A for AI-powered electronic health records for…
Barti Software raises $12M Series A for AI-powered electronic health records for eye care
(Image Credit: AdobeStock/Aliaksandr Marko) Barti Software announced a $12 million Series A investment led…
Renowned eye surgeon Dr Sajjad Fazili honoured with ‘excellence award’ at National Ophthalmology Conference – Rising Kashmir
Renowned eye surgeon Dr Sajjad Fazili honoured with ‘excellence award’ at National…
Worth Reading
Meeting expectations with evolving technology
Ağustos 26, 2025
/ Patient Education, Research & Studies, Technology & Innovation, Treatments & Surgery
Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Ağustos 26, 2025
/ Industry News, Patient Education, Research & Studies, Treatments & Surgery
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
Ağustos 26, 2025
/ Patient Education, Research & Studies
Next-generation IOLs advance complex cataract care
Ağustos 26, 2025
/ Patient Education, Research & Studies, Treatments & Surgery
Subscribe Now
Enter your email address below and subscribe to our newsletter